Video

Fecal Microbiota Transplantation Now and in the Future

Author(s):

For patients with C. difficile infection, fecal micriobiota transplantation may be their best bet when medication is not effective. Even as transplant becomes a more accepted approach for treating C. diff infection, researchers are investigating other areas it can be applied to.

For patients with C. difficile infection, fecal micriobiota transplantation may be their best bet when medication is not effective. Even as transplant becomes a more accepted approach for treating C. diff infection, researchers are investigating other areas it can be applied to.

Zain Kassam, MD, MPH, FRCPC, the Chief Medical Officer for OpenBiome discussed how the treatment is applied in treatment now, how it is viewed by the US Food and Drug Administration, and how it might be used in the future during Digestive Disease Week 2015 in Washington, DC.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.